Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

11.48 +0.88 (+8.30%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 29, 2022

Gainers Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million.

Via Benzinga

Analyst Ratings for NeoGenomics ↗

April 28, 2022

Analysts have provided the following ratings for NeoGenomics (NASDAQ:NEO) within the last quarter:

Via Benzinga

NeoGenomics: Q1 Earnings Insights ↗

April 27, 2022

NeoGenomics (NASDAQ:NEO) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

NeoGenomics Reports Revenue of $117 Million in the First Quarter

April 27, 2022

First-Quarter 2022 Results - Consolidated revenue increased 1% to $117 million; excluding 2021 COVID-19 PCR testing revenue, consolidated revenue increased 3% - Clinical Services revenue increased 2%...

From NeoGenomics, Inc.

Via AccessWire

NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay

April 25, 2022

FT. MYERS, FL / ACCESSWIRE / April 25, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced...

From NeoGenomics, Inc.

Via AccessWire

Why Is NeoGenomics (NEO) Stock Down Today? ↗

March 29, 2022

Cancer-testing company NeoGenomics is down more than 30% today after lowering earnings expectations. How far will NEO stock fall?

Via InvestorPlace

NeoGenomics Stock Gets Downgrade After CEO Resigns And Other Negative Updates ↗

March 29, 2022

NeoGenomics, Inc.

Via Benzinga

Earnings Scheduled For April 27, 2022 ↗

April 27, 2022

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.

Via Benzinga

NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022

April 11, 2022

Data demonstrates potential of RaDaR to predict clinical response in stage III urothelial cancer FT. MYERS, FL / ACCESSWIRE / April 11, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of...

From NeoGenomics, Inc.

Via AccessWire

NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D

April 11, 2022

NeoGenomics continues to add to its state-of-the-art multiomics solutions in world-class biopharma clinical trial and research services for global pharma companies FORT MYERS, FL / ACCESSWIRE / April...

From NeoGenomics, Inc.

Via AccessWire

NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022

April 08, 2022

FT. MYERS, FL / ACCESSWIRE / April 8, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to...

From NeoGenomics, Inc.

Via AccessWire

38 Stocks Moving In Thursday's Mid-Day Session ↗

April 07, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price...

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 08, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail...

Via Benzinga

NEOGENOMICS ALERT: Bragar Eagel & Squire, P.C. is Investigating NeoGenomics, Inc. on Behalf of NeoGenomics Stockholders and Encourages Investors to Contact the Firm

April 01, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Lost Money in NeoGenomics, Inc.?

March 31, 2022

From Gibbs Law Group

Via Business Wire

NEOGENOMICS ALERT: Bragar Eagel & Squire, P.C. is Investigating NeoGenomics, Inc. on Behalf of NeoGenomics Stockholders and Encourages Investors to Contact the Firm

March 31, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages NeoGenomics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – NEO

March 31, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of NeoGenomics, Inc. (NEO) on Behalf of Investors

March 30, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of NeoGenomics, Inc. (NEO) on Behalf of Investors

March 30, 2022

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of NeoGenomics, Inc. (NEO) on Behalf of Investors

March 29, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

53 Biggest Movers From Yesterday ↗

March 30, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...

Via Benzinga

Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of NeoGenomics, Inc. (NEO) Investors

March 29, 2022

From Kirby McInerney LLP

Via Business Wire

Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide ↗

March 29, 2022

U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 29, 2022

Gainers IGM Biosciences (NASDAQ:IGMS) shares rose 114.8% to $32.2 during Tuesday's regular session. IGM Biosciences's stock is trading at a volume of 31.6 million...

Via Benzinga

Stocks Higher as Ukraine-Russia Peace Talks Advance ↗

March 29, 2022

Optimism is high on Wall Street, as peace talks between Ukraine and Russia seem to advance.

Via Talk Markets

Mid-Day Market Update: Crude Oil Down 2.5%; IGM Biosciences Shares Jump ↗

March 29, 2022

U.S. stocks traded higher midway through trading, with the Dow jumping over 250 points on Tuesday.

Via Benzinga

Twilio Insider Trading Scandal: 8 Things for TWLO Stock Investors to Know ↗

March 29, 2022

Twilio (TWLO) stock is on the move Tuesday as the U.S. Securities and Exchange Commission (SEC) weighs in on an insider trading scandal.

Via InvestorPlace

36 Stocks Moving In Tuesday's Mid-Day Session ↗

March 29, 2022

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: IGMS) shares jumped 49.8% to $22.46. Sanofi SA (...

Via Benzinga

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm

March 29, 2022

From The Schall Law Firm

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

March 29, 2022

On Tuesday, 81 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Grupo Aval Acciones (NYSE:AVAL) was the biggest company by market cap to set a...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

NeoGenomics, Inc. - Common Stock (NQ:NEO)

All News about NeoGenomics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today